NSE filing, NSE: SUNREST. Summary written from the filing by ALFA Finder's alert engine.
Sunrest Lifescience Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹28.75 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹4.12 Cr
- P/E (TTM)
- 7.0×Sector 46.1×
- Promoter holding
- 53.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunrest Lifescience Ltd
All →Sunrest Lifescience Other Announcement
Sunrest Lifescience submitted a certificate confirming the non-applicability of corporate governance reporting requirements for the quarter ended 30th September 2026, due to its SME listing.
Sunrest Lifescience Board Meeting Outcome
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.
Sunrest Lifescience Capital Structure Change
Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.
Sunrest Lifescience Business Update
Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.
- Value
- ₹9.22 Cr
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.
- Value
- ₹10.00 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.